The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Sentinel Lymph Node Biopsy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sentinel Lymph Node Biopsy


High impact information on Sentinel Lymph Node Biopsy


Chemical compound and disease context of Sentinel Lymph Node Biopsy


Biological context of Sentinel Lymph Node Biopsy


Anatomical context of Sentinel Lymph Node Biopsy


Associations of Sentinel Lymph Node Biopsy with chemical compounds


Gene context of Sentinel Lymph Node Biopsy


Analytical, diagnostic and therapeutic context of Sentinel Lymph Node Biopsy


  1. Morbidity of dynamic sentinel node biopsy in penile carcinoma. Kroon, B.K., Lont, A.P., Valdés Olmos, R.A., Nieweg, O.E., Horenblas, S. J. Urol. (2005) [Pubmed]
  2. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. Kern, K.A. J. Am. Coll. Surg. (2002) [Pubmed]
  3. A caution regarding lymphatic mapping in patients with colon cancer. Feig, B.W., Curley, S., Lucci, A., Hunt, K.K., Vauthey, J.N., Mansfield, P.F., Cleary, K., Hamilton, S., Ellis, V., Brame, M., Berger, D.H. Am. J. Surg. (2001) [Pubmed]
  4. Lymphatic mapping and sentinel node biopsy in gastric cancer. Song, X., Wang, L., Chen, W., Pan, T., Zhu, H., Xu, J., Jin, M., Finley, R.K., Wu, J. Am. J. Surg. (2004) [Pubmed]
  5. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Dewachter, P., Mouton-Faivre, C., Benhaijoub, A., Abel-Decollogne, F., Mertes, P.M. Acta anaesthesiologica Scandinavica. (2006) [Pubmed]
  6. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? McMasters, K.M., Reintgen, D.S., Ross, M.I., Wong, S.L., Gershenwald, J.E., Krag, D.N., Noyes, R.D., Viar, V., Cerrito, P.B., Edwards, M.J. Ann. Surg. Oncol. (2001) [Pubmed]
  7. Effect on oximetry of dyes used for sentinel lymph node biopsy. Piñero, A., Illana, J., García-Palenciano, C., Cañizarese, F., Canteras, M., Cañadillas, V., Durán, E., Parilla, P. Archives of surgery (Chicago, Ill. : 1960) (2004) [Pubmed]
  8. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Sabel, M.S., Degnim, A., Wilkins, E.G., Diehl, K.M., Cimmino, V.M., Chang, A.E., Newman, L.A. Am. J. Surg. (2004) [Pubmed]
  9. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Albo, D., Wayne, J.D., Hunt, K.K., Rahlfs, T.F., Singletary, S.E., Ames, F.C., Feig, B.W., Ross, M.I., Kuerer, H.M. Am. J. Surg. (2001) [Pubmed]
  10. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Wong, S.L., Chao, C., Edwards, M.J., Simpson, D., McMasters, K.M. Am. J. Surg. (2001) [Pubmed]
  11. Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid. Lamichhane, N., Shen, K.W., Li, C.L., Han, Q.X., Zhang, Y.J., Shao, Z.M., Shen, Z.Z. Postgraduate medical journal. (2004) [Pubmed]
  12. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Fehr, M.K., Hornung, R., Varga, Z., Burger, D., Hess, T., Haller, U., Fink, D., von Schulthess, G.K., Steinert, H.C. The breast journal. (2004) [Pubmed]
  13. Transcription factors and other dysregulated proteins in melanoma prognosis. Karjalainen, J.M. Current oncology reports. (2001) [Pubmed]
  14. Patients blue on patent blue: An adverse reaction during four sentinel node procedures. Beenen, E., de Roy van Zuidewijn, D.B. Surgical oncology. (2005) [Pubmed]
  15. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Ozmen, V., Muslumanoglu, M., Cabioglu, N., Tuzlali, S., Ilhan, R., Igci, A., Kecer, M., Bozfakioglu, Y., Dagoglu, T. Breast Cancer Res. Treat. (2002) [Pubmed]
  16. Radiation safety with breast sentinel node biopsy. Stratmann, S.L., McCarty, T.M., Kuhn, J.A. Am. J. Surg. (1999) [Pubmed]
  17. Phytate technetium-99m versus dextran 500 technetium-99m in the sentinel lymph node biopsy. Paiva, G.R., Filho, R.S., Ferreira, L.M., Wagner, J., Nogueira, S.A., Novo, N.F., Juliano, Y., Rocha, J.L. Acta radiologica (Stockholm, Sweden : 1987) (2006) [Pubmed]
  18. Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Tsugawa, K., Ohnishi, I., Nakamura, M., Miwa, K., Yokoyama, K., Michigishi, T., Noguchi, M., Nonomura, A. Biomed. Pharmacother. (2002) [Pubmed]
  19. Re: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Bold, R.J. The American surgeon. (2002) [Pubmed]
  20. Staging N0 oral cancer: lymphoscintigraphy and conventional imaging. Thomsen, J.B., Sørensen, J.A., Grupe, P., Karstoft, J., Krogdahl, A. Acta radiologica (Stockholm, Sweden : 1987) (2005) [Pubmed]
WikiGenes - Universities